Literature DB >> 18154442

Towards an economic evidence base for pharmacogenetics: consideration of outcomes is key.

Katherine Payne.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18154442     DOI： 10.2217/14622416.9.1.1

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  2 in total

1.  Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain.

Authors:  David Gurwitz; Cristina Rodríguez-Antona; Katherine Payne; William Newman; Javier P Gisbert; Emma Gutiérrez de Mesa; Dolores Ibarreta
Journal:  Eur J Hum Genet       Date:  2009-02-18       Impact factor: 4.246

Review 2.  Issues surrounding the health economic evaluation of genomic technologies.

Authors:  James Buchanan; Sarah Wordsworth; Anna Schuh
Journal:  Pharmacogenomics       Date:  2013-11       Impact factor: 2.533
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.